Skip to main content

Advertisement

Log in

Evidence for the involvement of the RNA-dependent protein kinase (PKR) in the induction of human cytotoxic T lymphocytes against a synthetic peptide of HIV-1 by regulatory RNA

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Exogenous RNA molecules can be incorporated into eukaryotic cells and can exert a variety of biological effects. We have previously showed that exogenous RNAs obtained from lymphoid organs of animals immunized with synthetic peptides of HIV-1 are able to induce cell-mediated immune responses. In this study, animals were immunized with a synthetic peptide (pol: 476–484) of HIV-1, referred to as p9, which is a cytotoxic T lymphocyte (CTL) epitope. The RNA extracted from the lymphoid organs of animals immunized with p9 was termed p9-RNA. We have demonstrated that p9-RNA is active in inducing human CTL. The p9-RNA was also able to activate the RNA-dependent protein kinase (PKR) of human lymphocytes. The polyA(+) p9-RNA was the fraction responsible for the activation of this protein kinase. We also found that p9-RNA activates the transcription factor nuclear kappa B (NF-κB) by inducing the degradation of its inhibitor I-κB. Thus, these findings suggest that p9-RNA may act as a regulatory RNA and that the induction of CTL activity by p9-RNA could be mediated by PKR through NF-κB activation. It is known that CTL activity plays an important role in host defense against HIV-1 infection. Elucidating the molecular mechanism of p9-RNA could contribute to determining the basis for the use of p9-RNA as an immunomodulator in HIV-infected patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, Ho DD: Temporal association of cellular immune responses with the initial control of viremia in primary HIV-1 syndrome. J Virol 68: 4650–4655, 1994

    Google Scholar 

  2. Sokol S, Christian JL, Moon RT, Melton DA: Injected Wnt RNA induces a complete body axis. Xenopus embryos. Cell 67: 741–752, 1991

    Google Scholar 

  3. Zucchi TMAD, Cunha FQ, Ribeiro RA, Ferreira SH, De Lucca FL: Transformation of Aspergillus nidulans by RNA from rat macrophages stimulated with lipopolysaccharide. Cell Mol Biol 42: 235–240, 1996

    Google Scholar 

  4. De Lucca FL, Bertolini MC, Zini MN: In vitro transfer of reactivity to Trypanosoma cruzi antigens from rat cells to human cells with Immune RNA. J Infect Dis 145: 148–151, 1982

    Google Scholar 

  5. Steele E Jr, Wang BS, Richie JP, Ervin T, Yankee R, Mannick JA: Results of xenogeneic I-RNA therapy in patients with metastatic renal cell carcinoma. Cancer 47: 1286–1288, 1982

    Google Scholar 

  6. Martinon F, Krishnan S, Lenzen G, Magné R, Gomard E, Guillet JG, Lévy JP, Meulien P: Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. Eur J Immunol 23: 1719–1722, 1993

    Google Scholar 

  7. Boczkowski D, Nair SK, Snyder D, Gilboa E: Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 184: 465–472, 1996

    Google Scholar 

  8. Timmerman JM, Levy R: Dendritic cell vaccines for cancer immunotherapy. Annu Rev Med 50: 507–529, 1999

    Google Scholar 

  9. Schmitt WE, Stassar MJJG, Schmitt W, Little M, Cochlovius B: In vitro induction of a bladder cancer-specific T-cell response by mRNA-transfected dendritic cells. J Cancer Res Clin Oncol 127: 203–206, 2001

    Google Scholar 

  10. Passos GAS Jr, De Lucca FL: RNA-mediated transfer of cellular immunity to a synthetic env antigen of the human immunodeficiency virus (HIV-1). Mol Cell Biochem 108: 1–8, 1991

    Google Scholar 

  11. Sales VSF, Sawan FM, Watanabe MAE, Silva JS, Voltarelli JC, De Lucca FL: In vitro transfer of cellular immunity to synthetic peptides of HIV-1 to human lymphocytes with exogenous RNA. Mem Inst Oswaldo Cruz 91: 349–350, 1996

    Google Scholar 

  12. De Lucca FL, Sawan FM, Watanabe MAE, Souza LR: Effect of the calcium phosphate-mediated RNA uptake on the transfer of cellular immunity of a synthetic peptide of HIV-1 to human lymphocytes by exogenous RNA. Mol Cell Biochem 228: 9–14, 2001

    Google Scholar 

  13. Souza LR, De Lucca FL: Transfer of cellular immunity to a synthetic peptide of HIV-1 to human lymphocytes with exogenous RNA: Is the transcription factor NF-κB involved ? Proceedings of Fourth European Conference on Experimental AIDS Research, Tampere, Finland, Monduzzi Editore, 1999, pp 173–176

  14. Souza LR, Watanabe MAE, De Lucca FL: RNA-mediated activation of the transcription factor NF-κB in human lymphocytes: Implications for HIV immunopathogenesis? Proceedings of Fifth European Conference on Experimental AIDS Research, Madrid, Spain, Monduzzi Editore, 2000, pp 39–42

  15. Clemens MJ, Elia A: The double-stranded RNA-dependent protein kinase PKR: Structure and function. J Interferon Cytokine Res 17:503–524, 1997

    Google Scholar 

  16. Kumar A, Haque J, Lacoste J, Hiscott J, Williams BRG: Doublestranded RNA-dependent protein kinase activates transcription factor NF-κB by phosphorylating IκB. Proc Natl Acad Sci USA 91: 6288–6292, 1994

    Google Scholar 

  17. Gil J, Alcami J, Esteban M: Activation of NF-kappaB by the dsRNAdependent protein kinase, PKR involves the I kappa B kinase complex. Oncogene 19: 1369–1378, 2000

    Google Scholar 

  18. Karin M, Ben-Neriah Y: Phosphorylation meets ubiquitination: The control of NF-κB activity. Annu Rev Immunol 18: 621–663, 2000

    Google Scholar 

  19. Tsomides TJ, Walker BD, Eisen HN: An optimal viral peptide recognized by CD8+ T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein. Proc Natl Acad Sci USA 88: 11276–11280, 1991

    Google Scholar 

  20. White BN, De Lucca FL: Preparation and analysis of RNA. In: R.B. Turner (ed). Analytical Biochemistry of Insects. Elsevier Scientific Publishing Company, Amsterdam, 1977, pp 85–130

    Google Scholar 

  21. Bertollini MC, De Lucca FL: Poly(A)-containing RNA from the spleens of mice with Chagas' disease triggers in vitro macrophage resistance to Trypanosoma cruzi. J Protozool 33: 81–84, 1986

    Google Scholar 

  22. Sales VSF: Doctorate Thesis. School of Medicine of Ribeirão Preto University of São Paulo, Brazil, 1998

    Google Scholar 

  23. Li S, Nagai K, Koromilas AE: A diminished activation capacity of the interferon-inducible protein kinase PKR in human T lymphocytes. Eur J Biochem 267: 1598–1606, 2000

    Google Scholar 

  24. Dray S, Braun DP: Some perspectives on the transfer of cell-mediated immunity by immune RNA. Mol Cell Biochem 25: 15–30, 1979

    Google Scholar 

  25. Watanabe MAE, De Lucca FL: Anti-tumor effect of splenocytes treated with RNA from animals immunized with bovine mielin basic protein. Cell Mol Biol 42: 249–255, 1996

    Google Scholar 

  26. Watanabe MAE, Almeida DO, Serrano SV, Sales VSF, Soares FA, De Lucca FL: Immunotherapy of metastases with lymphocytes treated with exogenous RNA in mice bearing B16 melanoma. Cell Mol Biol 43: 393–398, 1997

    Google Scholar 

  27. Gale M Jr, Katze MG: Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol Ther 78: 29–46, 1998

    Google Scholar 

  28. Clemens MJ, Elia A: The double-stranded RNA-dependent protein kinase: Structure and function. J Interferon Cytokine Res 17: 503–524, 1997

    Google Scholar 

  29. Kaufman RJ: Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: A new role for an old factor. Proc Natl Acad Sci USA 96: 11693–11695, 1999

    Google Scholar 

  30. Gil J, Esteban M: Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis 5: 107–114, 2000

    Google Scholar 

  31. Li J, Petryshyn RA: Activation of the double-stranded RNA-dependent eIF-2 alpha kinase by cellular RNA from 3T3-F442A cells. Eur J Biochem 195: 41–48, 1991

    Google Scholar 

  32. Davis S, Watson JC: In vitro activation of the interferon-induced, double-stranded RNA-dependent protein kinase PKR by RNA from the 3′ untranslated regions of human α-tropomyosin. Proc Natl Acad Sci USA 93: 508–513, 1996

    Google Scholar 

  33. Nussbaum JM, Gunnery S, Mathews MB: The 3′-untranslated regions cytoskeletal muscle mRNAs inhibit translation by activating the double-stranded RNA-dependent protein kinase. Nucleic Acids Res 30: 1205–1212, 2002

    Google Scholar 

  34. Bhargava PM, Shanmugam G: Uptake of nonviral nucleic acids by mammalian cells. In: J.N. Davidson, W.E. Cohn (eds). Progress in Nucleic Acid Research and Molecular Biology, vol. 11. Academic Press, New York, 1971, pp 103–192

    Google Scholar 

  35. Steele G Jr, Wang BS, Mannick JA: Immune RNA and transfer factor. In: E. Mihich (ed). Immunological Approaches to Cancer Therapeutics. John Wiley and Sons Inc., New York, 1982, pp 257–276

    Google Scholar 

  36. Wang BS, Steele G Jr, Mannick JA, Fallon M, Onikul SR: In vivo effects and parallel in vitro cytotoxicity of splenocytes harvested from treated or control C57BL/6J mice after adjuvant immunotherapy of pulmonary metastases using xenogeneic RNA specific to B16 murine melanoma. Cancer Res 39: 1702–1707, 1979

    Google Scholar 

  37. Richie JP, Wang BS, Steele GD Jr, Wilson RE, Mannick JA: In vivo and in vitro effects of xenogeneic immune ribonucleic acid in patients with advanced renal cell carcinoma: A phase I study. J Urol 126: 24–28, 1981

    Google Scholar 

  38. Gil J, Rullas J, Garcia MA, Alcami J, Esteban M: The catalytic activity of dsRNA-dependent protein kinase, PKR, is required for NF-kappaB activation. Oncogene 20: 385–394, 2001

    Google Scholar 

  39. Eddy SR: Noncoding RNA genes. Curr Opin Genet Dev 9: 695–699, 1999

    Google Scholar 

  40. Lau NC, Lim LP, Weistein EG, Bartel DP: An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294: 858–862, 2001

    Google Scholar 

  41. Liu AY, Torchia BS, Migeon BR, Siliciano RF: The human NTT gene: Identification of a novel 17-kb noncoding nuclear RNA expressed in activated CD4+ T cells. Genomics 39: 171–174, 1997

    Google Scholar 

  42. Erdmann VA, Szymanski M, Hochberg A, de Groot N, Barciszewski J: Collection of mRNA-like non-coding RNAs. Nucleic Acids Res 27: 192–195, 1999

    Google Scholar 

  43. Erdmann VA, Barciszewska MZ, Hochberg A, de Groot N, Barciszewski J: Regulatory RNAs. Cell Mol Life Sci 58: 960–977, 2001

    Google Scholar 

  44. Erdmann VA, Barciszewska MZ, Szymanski M, Hochberg A, de Groot N, Barciszewski J: The non-coding RNAs as riboregulators. Nucleic Acids Res 29: 189–193, 2001

    Google Scholar 

  45. Eddy SR: Non-coding RNA genes and the modern RNA world. Nat Rev Genet 2: 919–929, 2001

    Google Scholar 

  46. Mattick JS, Gagen MJ: The evolution of controlled multitasked gene networks: The role of introns and other nonconding RNAs in the development of complex organisms. Mol Biol Evol 18: 1611–1630, 2001

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Lucca, F.L., Sales, V.S., Souza, L.R. et al. Evidence for the involvement of the RNA-dependent protein kinase (PKR) in the induction of human cytotoxic T lymphocytes against a synthetic peptide of HIV-1 by regulatory RNA. Mol Cell Biochem 238, 19–26 (2002). https://doi.org/10.1023/A:1019983102017

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1019983102017

Navigation